US Patent Issued to KITE PHARMA on May 19 for "Chimeric antigen receptor T cell therapy" (California Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,603, issued on May 19, was assigned to KITE PHARMA INC. (Santa Monica, Calif.).

"Chimeric antigen receptor T cell therapy" was invented by Adrian Bot (Beverly Hills, Calif.), John Rossi (Newbury Park, Calif.), Vicki Plaks (Santa Monica, Calif.), Szu-Ting Chou (Los Angeles), William Go (Thousand Oaks, Calif.) and Jenny Jiyun Kim (Thousand Oaks, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure provides methods of treating a malignancy comprising administering an effective dose of a chimeric antigen receptor genetically modified T cell immunotherapy and methods for manufacturing such immunotherapy. Some aspects of the disclosure rela...